Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
16-September-2008 16:15:17 - Salbutamol Redirected from Albuterol This article or section includes a list of references or external links, but its sources remain unclear because it lacks in-text citations. You can improve this article by introducing more precise citations where appropriate. Salbutamol Systematic IUPAC name 4-2-tert-butylamino-1-hydroxyethyl-2-hydroxymethylphenol Identifiers CAS number 18559-94-9 ATC code R03AC02 R03CC02 PubChem 2083 DrugBank APRD00553 Chemical data Formula C13H21NO3 Mol. mass 239.311 SMILES eMolecules PubChem Pharmacokinetic data Bioavailability ? Metabolism Hepatic Half life 1.6 hours Excretion Renal Therapeutic considerations Pregnancy cat. AAU CUS Legal status Pharmacist Only S3AU ?CA POMUK â„ž-onlyUS Routes Oral, inhalational, IV Salbutamol INN or albuterol USAN is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease. Salbutamol sulfate is usually given by the inhaled route for direct effect on bronchial smooth muscle. This is usually achieved through a metered dose inhaler MDI, nebuliser or other proprietary delivery devices e.g. Rotahaler or Autohaler. In these forms of delivery, the maximal effect of Salbutamol can take place within five to twenty minutes of dosing, though some relief is immediately seen. Salbutamol can also be given orally as an inhalant or intravenously. However, some asthmatics do not have the required DNA base sequence in a specific gene and may not respond to these medications. Salbutamol became available in the United Kingdom in 1969 and in the United States in 1980 under the trade name Ventolin. Contents 1 Clinical use 2 Side Effects / Health Consequences 3 Ban of CFC-containing albuterol inhalers 4 Petition to keep CFC-containing albuterol inhalers 5 Diet and bodybuilding use 6 References 6.1 Additional notes 7 External links Clinical use Salbutamol is specifically indicated in the following conditions: Acute asthma Symptom relief during maintenance therapy of asthma and other conditions with reversible airways obstruction including COPD Protection against exercise-induced asthma Can induce Hypokalaemia, especially in patients with renal failure Can be aerosolized with a nebulizer for patients with cystic fibrosis, along with ipratropium bromide and pulmozyme. As a β2-agonist, salbutamol also finds use in obstetrics. Intravenous salbutamol can be used as a tocolytic to relax the uterine smooth muscle to delay premature labour. Whilst preferred over agents such as atosiban and ritodrine, its role has largely been replaced by the calcium-channel blocker nifedipine which is more effective, better tolerated and orally administered.1 Side Effects / Health Consequences Tachycardia Tremors Shakiness, nervousness Hyperkinesis Headache Insomnia Nausea and Vomiting Reactive bronchospasm Ban of CFC-containing albuterol inhalers Ventolin inhaler Ventolin inhaler The U.S. Food Drug Administration in April of 2005 mandated that all including albuterol inhalers containing chlorofluorocarbons CFCs will be prohibited in the United States as of 12/31/2008. CFC inhalers had previously been given essential use status, exempting it from a CFC-production ban, however in accordance with the Montreal Protocol they will be phased out; in many other countries patients have been transitioned to non-CFC based inhalers using hydrofluoroalkane HFA propellant. Pharmaceutical manufacturers are expected to produce adequate supplies of alternative HFA inhalers by 2009.citation needed One drawback of this transition to HFA inhalers is that due to patent restrictions all of the HFA albuterol inhalers are brand-name ProAir, Proventil, and Ventolin. They cost approximately $20 more per inhaler than existing generic CFC albuterol inhalers. Three of the four available albuterol/levalbuterol HFA inhalers on the market also contain 10-14% ethanol by weight. Ventolin HFA is the exception. For reference, ethanol is a known bronchoconstrictor2. Generic HFA albuterol inhalers are not expected on the market until 2017 due to existing patents, although some pharmaceutical companies will offer discounts for those who cannot afford the HFA inhalers.citation needed Another drawback that is coming to light now as the use of HFA/HFA+ethanol inhalers is expanding seems to be a far higher intolerance of the new inhalers compared to CFC propellant in patients. Registered complaints run the gamut from doesn't seem to work as well all the way to serious anaphylaxis in response to using an HFA or HFA+ethanol inhaler.3 Albuterol is widely used, and accounts for anywhere from 78% of all bronchodilator prescriptions in 2005 to 85% in 2008. 4 However, patients in the United States who cannot tolerate the HFA albuterol inhalers will not have a single albuterol alternative available to them domestically after December 31, 2008.5 The FDA did not approve any alternatives to HFA and there are few standard inhaled lung medications in the United States that come in Dry Powder Inhaler DPI versions. Noticibly missing is albuterol in DPI form in the United States, although it is available in most of the rest of the world in salbutamol DPIs. The benefits of transitioning to HFA inhalers include 1 increased drug deposition in the distal airways, 2 more consistent drug delivery from nearly empty canisters, and 3 more consistent drug delivery at a greater range of canister temperatures. It should be noted that the spray force of HFA inhalers is less than that of CFC inhalers, which may mislead some patients to believe that they may not be receiving enough albuterol when in fact they are seeing the benefits as outlined above.citation needed Petition to keep CFC-containing albuterol inhalers There is a place to record problems with HFA/HFA+ethanol inhalers and a petition to keep CFC inhalers on the market online at: 13 Diet and bodybuilding use Salbutamol is taken by some as an alternative to Clenbuterol for purposes of fat burning.6 References ^ Rossi S Ed. 2004. Australian Medicines Handbook 2004 AMH. Adelaide: Australian Medicines Handbook. ISBN 0-9578521-4-2. ^ Effect of ethanol on airway caliber and nonspecifi...Allergy. 1996 - PubMed Result ^ a b Home Page ^ IMS Health Sales Prescription data for all inhalers sales and prescriptions July 2008 ^ FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers Now ^ Carter WJ, Lynch ME September 1994. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metab. Clin. Exp. 43 9: 1119-25. PMID 7916118. Additional notes Moore NG, Pegg GG, Sillence MN September 1994. Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am. J. Physiol. 267 3 Pt 1: E475-84. PMID 7943228. Schiffelers SL, Saris WH, Boomsma F, van Baak MA May 2001. beta1- and beta2-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J. Clin. Endocrinol. Metab. 86 5: 2191-9. PMID 11344226. van Baak MA, Mayer LH, Kempinski RE, Hartgens F July 2000. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 32 7: 1300-6. PMID 10912897. Caruso JF, Hamill JL, De Garmo N February 2005. Oral albuterol dosing during the latter stages of a resistance exercise program. J Strength Cond Res 19 1: 102-7. doi:10.1519/R-14793.1. PMID 15705021. Caruso JF, Signorile JF, Perry AC, et al November 1995. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 27 11: 1471-6. PMID 8587482. Martineau L, Horan MA, Rothwell NJ, Little RA November 1992. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin. Sci. 83 5: 615-21. PMID 1335400. S Desaphy JF, Pierno S, De Luca A, Didonna P, Camerino DC March 2003. Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders. Mol. Pharmacol. 63 3: 659-70. PMID 12606775. Maki KC, Skorodin MS, Jessen JH, Laghi F June 1996. Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men. Metab. Clin. Exp. 45 6: 712-7. PMID 8637445. External links Albuterol Volmax Drug Information v d e Adrenergic agonists models/most important in CAPS α α1 METHOXAMINE - Methylnorepinephrine - Oxymetazoline - PHENYLEPHRINE - Metaraminol α2 4-NEMD - CLONIDINE - Guanfacine - Guanabenz - Guanoxabenz - Guanethidine - Xylazine - METHYLDOPA - Apraclonidine - Brimonidine - Detomidine - Dexmedetomidine - Lofexidine - Romifidine - Tizanidine - Xylometazoline Undetermined/ unsorted Amidephrine - Amitraz - Anisodamine - Ergotamine - Indanidine - Medetomidine - Mephentermine - Midodrine - Mivazerol - Naphazoline - Norfenefrine - Octopamine - Phenylpropanolamine - Rilmenidine - Synephrine - Talipexole - Tetrahydrozoline - Xylometazoline β β1 DOBUTAMINE - Dopamine - Denopamine - Xamoterol β2 Short acting β2-agonists: SALBUTAMOL/Levosalbutamol - Fenoterol - TERBUTALINE - Pirbuterol - Procaterol - Bitolterol - Rimiterol - Carbuterol - Tulobuterol - Reproterol - Dopexamine Long acting β2-agonists LABA: Arformoterol - Bambuterol - Clenbuterol - Formoterol - Salmeterol Orciprenaline/metaproterenol - Ritodrine - Hexoprenaline - Indacaterol β3 Amibegron - Solabegron Undetermined/ unsorted Arbutamine - Befunolol - Isoxsuprine - Nylidrin - Oxyfedrine - Prenalterol - Ractopamine - Bromoacetylalprenololmenthane - Broxaterol - Cimaterol - Higenamine - Mabuterol - Methoxyphenamine - Tretoquinol - Zinterol Nonselective β ISOPRENALINE/ISOPROTERENOL α and β Epinephrine α1+2, β1+2 - Norepinephrine α1+2, β1 - Cirazoline - Etilefrine Indirect/ mixed Indirect presynaptic norepinephrine release: Amphetamine - Tyramine Mixed: Ephedrine - Pseudoephedrine Cocaine see also monoamine oxidase inhibitor v d e Drugs for obstructive airway diseases: asthma/COPD R03 Adrenergics, inhalants Short acting β2-agonists Salbutamol/Levosalbutamol Fenoterol Terbutaline Pirbuterol Procaterol Bitolterol Rimiterol Carbuterol Tulobuterol Reproterol Long acting β2-agonists LABA Arformoterol Bambuterol Clenbuterol Formoterol Salmeterol Ultra LABA: Indacaterol other Epinephrine Hexoprenaline Isoprenaline Isoproterenol Orciprenaline Metaproterenol Glucocorticoids Beclometasone Budesonide Ciclesonide Fluticasone Mometasone Anticholinergics/ muscarinic antagonist Ipratropium Tiotropium Mast cell stabilizers Cromoglicate Nedocromil Xanthines Aminophylline Doxofylline Theobromine Theophylline Leukotriene antagonists Montelukast Pranlukast Zafirlukast Lipoxygenase inhibitor Zileuton Thromboxane receptor antagonists Ramatroban Seratrodast Combination products Budesonide/formoterol Fluticasone/salmeterol Ipratropium/salbutamol v d e Phenethylamines 2C-B 2C-C 2C-D 2C-E 2C-I 2C-N 2C-T-2 2C-T-21 2C-T-4 2C-T-7 2C-T-8 3C-E 4-FMP Bupropion Cathine Cathinone Clenbuterol DESOXY Dextroamphetamine Methamphetamine Diethylcathinone Dimethylcathinone DOC DOB DOI DOM bk-MBDB Dopamine Br-DFLY Ephedrine Epinephrine Escaline Etafedrine Fenfluramine Levosalbutamol Levmetamfetamine MBDB MDA MDMA MDMC MDEA MDPV Mescaline Methcathinone Norepinephrine Phentermine Salbutamol Tyramine Venlafaxine Retrieved from http://en..org/wiki/Salbutamol Categories: Alcohols | Amines | Asthma | Beta-adrenergic agonists | Bronchodilators | Phenethylamines | PhenolsHidden categories: Articles lacking in-text citations | All articles with statements | Articles with statements since May 2008 Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages Deutsch Español Français Italiano עברית Magyar Nederlands Polski РуÑ?Ñ?кий Suomi This page was last modified on 9 August 2008, at 05:50
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.